Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for Prevention of Progression in Peutz-Jeghers Syndrome
NCT06722534Recruiting
- Sponsor
- Air Force Medical University
- Start
- Feb 2025
- Primary completion
- Jan 2029
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, double-blind trial in Peutz-Jeghers syndrome (PJS) comparing Celecoxib group with Placebo group (2 arms). Primary endpoint: The progression of small bowel disease (composite end point) at 2 years. Started Feb 2025; status: recruiting.
02
Drugs
celecoxib
03
Conditions
Peutz-Jeghers syndrome (PJS)
Beyond the preview
Go deeper on NCT06722534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06722534.